// App-Quantinova.ai

3696 : Salvage Therapy with Bortezomib Plus Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma: Initial Results of a Phase II Trial (Alliance/CALGB 50501)

Researchers

Presenter

  • Sin-Ho Jung

Principal Investigators

  • Jeffrey Johnson

  • Ann LaCasce

  • Kristie A. Blum

  • Nancy L. Bartlett

  • Bruce D. Cheson

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Peripheral neuropathy

  • Mantle cell lymphoma

  • Thrombocytopenia

  • Venous thrombosis

  • Lymphomas

  • Dyspnea

  • Anemia

Biomarkers

  • Cluster of Differentiation 5

Drug/Treatment

  • Lenalidomide

  • Thalidomide

  • Bortezomib

  • Rituximab

Outcome

  • N/A

Study Design

  • pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved